Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • GSK-3
    (70)
  • CDK
    (20)
  • Apoptosis
    (11)
  • Wnt/beta-catenin
    (10)
  • Akt
    (4)
  • ERK
    (4)
  • MMP
    (4)
  • NF-κB
    (4)
  • Src
    (4)
  • Others
    (4)
Filter
Search Result
Results for "

gsk-3 β

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    78
    TargetMol | Inhibitors_Agonists
  • Peptide Products
    3
    TargetMol | Peptide_Products
  • Natural Products
    9
    TargetMol | Natural_Products
  • Recombinant Protein
    3
    TargetMol | Recombinant_Protein
  • Antibody Products
    2
    TargetMol | Antibody_Products
CHIR-99021
Laduviglusib, CT99021, CHIR-99021
T2310252917-06-9
CHIR-99021 (CT99021) is an activator of the Wnt β-catenin signaling pathway and a GSK-3α β inhibitor (IC50=10 6.7 nM) with selective and oral activity.CHIR-99021 induces cellular autophagy, which enhances self-renewal in mouse and human embryonic stem cells.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
gnf4877
T114472041073-22-5In house
GNF4877 is a potent inhibitor of DYRK1A and GSK (IC50s: 6 nM and 16 nM, respectively), resulting in the blockade of nuclear export of nuclear factor of activated T-cells (NFATc) and increased β-cell proliferation.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
GSK-3β inhibitor 8
GSK Inhibitor XVIII
T355561139875-74-3In house
GSK-3β inhibitor 8 (GSK Inhibitor XVIII) is a potent and selective GSK-3β inhibitor with an IC50 value of 64 nM.GSK-3β inhibitor 8 is a thienopyrimidine derivative that negatively regulates the Wnt signaling pathway and stimulates β-cell proliferation.
  • Inquiry Price
8-10 weeks
Size
QTY
r547
Ro 4584820
T6312741713-40-6In house
R547 (Ro 4584820) is a potent ATP-competitive inhibitor of CDK1 2 4 with Ki of 2 nM 3 nM 1 nM. It is less potent to CDK7 and GSK3α β, while inactive to other kinases. Phase 1.
  • Inquiry Price
Size
QTY
Citric acid trilithium salt tetrahydrate
Trilithium citrate tetrahydrate, Lithium citrate tribasic tetrahydrate
T02566080-58-6
Citric acid trilithium salt tetrahydrate (Lithium citrate tribasic tetrahydrate) , the active component of Lithium, is a medicine used in the therapy of psychiatric disease. It has shown the effects of signaling pathways and metabolic in the brain based on the particular disease and clinical condition model. According to the reports, Citric acid trilithium salt tetrahydrate was used as a mood stabilizer when treating bipolar mood disorders (BD) and lower the risk of self-harm in BD patient. In addition,Citric acid trilithium salt tetrahydrate has been the choice drug in the therapy of acute manic episodes.Citric acid trilithium salt tetrahydrate also could dissolve uric acid crystals in urine achieved from patients with gout. Besides,Citric acid trilithium salt tetrahydrate have some dose-dependent side-effects. The the main side-effects of Lithium Citrate is the tendency to inhibit the prostatic acid phosphatase enzyme (PAP), which result in the accumulation of PAP.
  • Inquiry Price
Size
QTY
Cromolyn sodium
Sodium cromoglycate, FPL-670, FPL 670 (Cromolyn) Disodium, Disodium Cromoglycate
T126015826-37-6
Cromolyn sodium (FPL-670) is a chromone complex that acts by inhibiting the release of chemical mediators from sensitized mast cells.
  • Inquiry Price
Size
QTY
Tideglusib
NP-12, NP031112
T3067865854-05-3
Tideglusib (NP031112), a non-ATP competitive inhibitor of glycogen synthase kinase 3 (GSK-3), is with anti-inflammatory and neuroprotective activities.
  • Inquiry Price
Size
QTY
GSK-3 Inhibitor 5
4-Cyanophenacyl bromide
T7755420099-89-2
GSK-3 Inhibitor 5 (4-Cyanophenacyl bromide) is a ketone derivative that is used as an intermediate in pharmaceuticals and organic synthesis, and inhibits glycogen synthase kinase 3 (GSK-3).
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
AZD1080
T1741612487-72-6
AZD1080 is a selective, orally active, brain permeable GSK3 inhibitor.
  • Inquiry Price
Size
QTY
KenPaullone
NSC-664704, 9-Bromopaullone
T2247142273-20-9
KenPaullone (9-Bromopaullone), a potent CDK1, CDK2 and CDK5 inhibitor, as new enhancer for iTreg cell differentiation. Kenpaullone promotes iTreg cell differentiation through increased and prolonged transcription of foxp3 gene by enhancing TGFβ-Smad3 signaling pathway.
  • Inquiry Price
Size
QTY
TBB
NSC 231634, Casein Kinase II Inhibitor I, 4,5,6,7-tetrabromobenzotriazole
T269517374-26-4
TBB (NSC-231634)(NSC-231634) is a highly selective, ATP GTP-competitive inhibitor of casein kinase-2 (CK2).
  • Inquiry Price
Size
QTY
sns-032
SNS032, BMS-387032
T6049345627-80-7
SNS-032 (BMS-387032) is a selective inhibitor of CDK2 (IC50: 48 nM), exhibiting 10- and 20-fold selectivity over CDK1 and CDK4, respectively. It is also sensitive to CDK7 (IC50: 62 nM) and CDK9 (IC50: 4 nM), with no effect on CDK6.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
AT7519
T6205844442-38-2
AT7519 is a CDK1 2 4 6 9 inhibitor (IC50: 10-210 nM). It is less effective to CDK3 and little active to CDK7.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
PHA-767491
PHA767491, PHA 767491, CAY10572
T6206845714-00-3
PHA-767491 (CAY10572) is a potent ATP-competitive dual Cdc7 CDK9 inhibitor with IC50 of 10 nM and 34 nM, respectively.
  • Inquiry Price
Size
QTY
GSK3a-IN-38
T776711062138-03-7
GSK3a-IN-38 is a novel small molecule compound that has inhibitory effects on GSK-3a.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
gsk-3β inhibitor 10
T97251198098-03-1
GSK-3β inhibitor 10 has skin-whitening, anti-oxidizing and PPAR activities.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
chir 98024
CHIR98014
T3074556813-39-9
CHIR 98024 is a potent GSK-3α β inhibitor with IC50 of 0.65 nM 0.58 nM in cell-free assays, with the ability to distinguish GSK-3 from its closest homologs Cdc2 and ERK2.
  • Inquiry Price
7-10 days
Size
QTY
1-Azakenpaullone
azakenpaullone
T6358676596-65-9
1-Azakenpaullone (azakenpaullone) is a potent and selective GSK-3β inhibitor with IC50 of 18 nM, >100-fold selectivity over CDK1 cyclin B and CDK5 p25.
  • Inquiry Price
4-6 weeks
Size
QTY
BIO-acetoxime
GSK-3 Inhibitor X, BIA
T6787667463-85-6
BIO-acetoxime (GSK-3 Inhibitor X) is a potent dual GSK3α β inhibitor with IC50 of 10 nM, >240-fold selectivity over CDK5 p25, CDK2 cyclin A and CDK1 cyclin B.
  • Inquiry Price
Size
QTY
A-443654
T14072552325-16-3
A-443654, a pan-Akt inhibitor, exhibits equal potency against Akt1, Akt2, and Akt3 within cells (Ki=160 pM).
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
TCS 21311
NIBR3049
T170191260181-14-3
TCS 21311 (NIBR3049) is an effective and highly selective inhibitor of JAK3 (IC50: 8 nM). TCS 21311 inhibits PKCα, PKCθ, and GSK (IC50s: 13, 68, and 3 nM, respectively). It displays >100-fold selectivity over JAK1, JAK2, and TYK2.
  • Inquiry Price
6-8 weeks
Size
QTY
AT7519 Hydrochloride
AT7519 HCl, AT 7519 hydrochloride salt
T1778902135-91-5
AT7519 Hydrochloride (AT7519 HCl) is a multi-CDK inhibitor for CDK1, 2, 4, 6 and 9.
  • Inquiry Price
Size
QTY
AZD2858
T1957486424-20-8
AZD2858 is a selective GSK-3 inhibitor, inhibiting tau phosphorylation at the S396 site and activating Wnt signaling pathway.
  • Inquiry Price
Size
QTY
Bikinin
Abrasin
T1965188011-69-0
Bikinin (Abrasin), a potent inhibitor of plant GSK-3 Shaggy-like kinase, activates BR signaling downstream of the BR receptor.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale